在醫療技術的日益進步下，心血管疾病的手術的時間得以大幅縮短，醫療風險也大幅降低。以心房中隔缺損為例，透過醫療器材設計的革命性創新，配合發展成熟的心導管醫療手術，可以讓病人在傳統的開心手術外有另一選擇，而達到有效且易於醫生操作的目的。
本研究以個案公司所代理之心房中隔關閉器為研究對象，由外部的產業分析、相關法規出發，探討醫療器材在研發過程中所需符合的要求與規範，及醫療器材產品生命週期的特性。在產品研發創新與價值創造上，則探討如何針對病患快速康復、降低後遺症與提高醫生在手術進行時的操作方便性為目標，進行產品材料與構造的設計創新，提高醫生與病患的使用意願及滿意度。由於醫療器材必須配合現有的手術方式，相關的流程與監測技術創新更可有效提升醫療器材創新的綜效，同時為醫生與病患創造最大的價值。
本研究也將結合理論於實務應用於個案公司的經營，發揮具策略性思考的價值。目前個案公司的產品代理與服務，已於現有市場奠定良好的基礎，未來拓展新興市場時，可透過與原廠良好的合作關係與經驗分享，提供新興市場高品質的產品與服務，創造高階與差異化的綜效，以個案公司在市場上多年行銷與服務的優勢，整合資源、開創新機。

Due to the advance of medical technology, Cardiovascular surgery time is significantly shortened and medical risk is reduced. Through the innovation of medical equipment revolutionary design and the development of advanced cardiac catheterization procedure, using Atrial Septal Occluder can apply another choice at traditional open heart surgery, while doctors operate to achieve effective and easy to treat the Atrial Septal Defects.
The case study is research by the company which agent Atrial Septal Occluder. It investigates the Research and development of medical equipment in the course of the qualifying requirements and regulations, and medical equipment product life cycle characteristics by analyzing external industry, relevant laws and regulations.
In the innovation of product development and value creation, this research try to explore how patients cured rapidly, reduce complications and help the doctor improve surgery operation to push the Product materials and structural design innovation. According to the innovation, it would improve the intention and satisfaction of doctors and patients to use. Because of medical equipment must fit into existing surgical procedure, related processes and monitoring of technological innovation can more effectively enhance the synergy of innovative medical devices
The study also will combine the theory in practice applied to the case company, play with the value of strategic thinking. The company agents this product and service from this case study have laid a good foundation for the current market. Through a good working relationship and share working experience with manufacturers, the case company could provide emerging markets with high quality products and services. It will help case company to integrate resources and open up new opportunities in the future.

中文部份
1.Larry Selden & Ian C﹒MacMillan，客戶導向創新(Manage Customer-Centric
Innovation-Systematically)，《哈佛商業評論．全球中文版》，2006年4月。
2.Lance A.Bettencourt & Anthony W. Ulwick，顧客是你的創意中心(The Customer-
Centered Innovation Map)，《哈佛商業評論．全球中文版》，2008年9月，頁70∼77。
3.Ravi Chhatpar，設計與策略同步(Innovate Faster by Melding Design and
Strategy)，《哈佛商業評論．全球中文版》2007年9月。
4.W. Chan Kim、Renee Mauborgne (2005)，黃秀媛譯，藍海策略：開創無人競爭的全新
市場，台北，天下文化，洪順慶(2006），台灣品牌競爭力，台北，天下雜誌。
5.工業技術研究院IEK-IT IS 計畫(2003)。
6.彭桂清、徐苑琳( 2007)，3M成功秘訣：無限創新，台北，漢宇出版社。
7.卓力仁(2007)，醫療器材認證系統專欄，台灣衛理品質季刊，第15期，頁22-27。
8.黃博偉(2007) ，醫療器材工業年鑑，台北，工研院產業經濟與資訊服務中心。
9.張慈映(2008)，醫療器材產業發展現況與趨勢，生物科技產業與投資趨勢研習會，
新竹：工業技術研究院產經中心。
10.張慈映(2009)，2009年第二季我國醫療器材產業回顧與展望，新竹：工業技術研究院。
11.梁瓊如(2009)，價值創新管理講義，國立台灣科技大學財務金融研究所。
12.梁瓊如(2009)，核心競爭力講義，國立台灣科技大學財務金融研究所。

英文部份
1.Adner, Ron (2006), “Match Your Innovation Strategy to Your Innovation
Ecosystem”, Harvard Business Review,vol.84, No4,pp.98-107
2.Alonzo Canada, Pete Mortensen and Dev Patnaik (2007) “Design Strategies for
Technology Adoption”,Design Management Review Vol. 18 No. 4
3.Atlie F, Rosas M, Granados N, Zabal C, Buendia A, Calderon J.(2001)
“Surgical treatment for secundum atrial septal defects in patients >40
years old, a randomized clinical trial”, J Am Coll Cardiol ;38:2035-42.
4.Berger F. Vogel M. Alexi-Meskishvil: V, Lange P. (1999) “Comparision of
results and complications of surgical and Amplatzer device closure of atrial
septal defects” , JThorac Cardiovasc surg;118:674-80.
5.B. Tracy (2000), “The 100 Absolutely Unbreakable Laws of Business
Success”, Berrett-Koehler Publishers, Inc.CA.
6.Bhaskar Chakravorti (2004),“The New Rules for Bringing Innovations to
Market” ,Harvard Business Review(Apr.2004,vol.31,pp.60)
7.Chessa M, Carminati M, Butera G, Bini RM, Drago M, Rosti L, Giamberti A,Pome
G, Bossone E, Frigiola A.(2002), “ Early and late complications associated
withtranscatheter occlusion of secundum atrial septal defect.”, J Am Coll
Cardiol;39:1061-5.
8.Du ZD, Hijazi ZM, Kleinman CS, Silverman NH, Larntz K.(2002) “Comparison
between transcatheter and surgical closure of secundum atrial septal defect
in children and adults”, J Am Coll Cardiol; 39:1936-1834.
9.Eric Von Hippel, Stefan Thomke, Mary Sonnack (1999), “Creating
Breakthroughs at 3M”, Harvard Business Review on Innovation.
10.Gary Hamel (2006), “The Why, What, and How of Management Innovation”,
Harvard Business Review (February 2006).
11.Giovanni Gavetti、Jan W.Rivkin(2005)“How Strategists Really Think：Tapping
the Power of Analogy”, Harvard Business Review (April 2005)
12.Jemielity M, Dysszkiewicz W, Paluszkiewicz L, Perek B, Buczkowski P. (2001)
“Do patients over 40 years of age benefit from surgical closure of atrial
septal defects?” , Heart;85:300-303.
13.Kim, W. Chan & Mauborgne, Rene (2000),“Knowing a Winning Business Idea
When You See One”,Harvard Business Review, vol.77, No5，pp.129-138
14.Kim, W. Chan & Mauborgne, Rene (2004),“Blue Ocean Strategy”, Harvard
Business Review Article,vol.82, No10,pp.76-84
15.Kanter, Rosabeth Moss (2006), “Innovation: The Classic Traps ”,Harvard
Business Review,vol.84, No11, pp.72-83
16.Larry Selden＆Ian C. MacMillan(2006), “Manage Customer-Centric Innovation-
Systematically”,Harvard Business Review(April 2006)
17.Scott D.Anthony (2006), “Mapping Your Innovation Stategy”, Harvard
Business Review (May 2006).
18.Thomke, Stefan , Hippel , Eric Von (2002),“Customers as Innovators: A New
Way to Create Value”,Harvard Business Review,vol.80, No4,pp.76
19.Vijay Govindarajan、Chris Trimble(2005),“Building Breakthrough Businesses
within Established Organizations”, Harvard Business Review (May 2005).
20.Youngme Moon (2005),“Break Free from the Product Life Cycle”, Harvard
Business Review (May 2005)
21.Zook ,Chris & Allen , James (2003), “ Growth Outside the Core”, Harvard
Business Review,vol.81, No12,pp.69